MAPT and dementia: Temporally, pre-clinical and pre-dementia phases of AD can be observed by reducedamyloid-β 1-42 protein levels in CSF.59 In a later phase, albeit still clinically asymptomatic, theneuronal degeneration markers tau and phosphorylated tau protein can also bedetected.